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ABSTRACT
Triparanol  and  20,25-diazacholesterol  inhibit  cholesterol  biosynthesis  and  result  in  the
accumulation  of  desmosterol.  AY-9944,  another  inhibitor,  produces  an  accumulation  of
7-dehydrocholesterol.  Adult male  C3H  mice  receive  one  of these  drugs  intraperitoneally.
Livers,  adrenal  glands,  and  testes from  each drug group  are  excised,  and portions  of each
are  analyzed  by  a  modified  Liebermann-Burchard  reaction  for  quantitation  of  sterols.
Adrenals  and testes  are  examined  also  by electron  microscopy.  Fine-structural  localization
of  acid  phosphatase  has  been  studied  in  triparanol-treated  adrenal  glands.  Biochemical
analysis  reveals  that  14-64%  of the  sterols  occurs  as  desmosterol  or  7-dehydrocholesterol.
Fine-structural  alterations  in  the  adrenal  glands  and  testes  from each  drug group  are  es-
sentially  identical.  The  predominant  cytological  feature  is  the  occurrence  of  increased
numbers  of pleomorphic,  unit-membrane-limited,  electron-opaque,  cytoplasmic  inclusions.
Hence,  the cellular  modifications  following  triparanol  administration  are not  unique,  as
has been  suggested.  They represent  a generalized  phenomenon,  probably  related  to inhibi-
tion of  cholesterol  biosynthesis,  which  is  an  effect  common  to each  drug.  Lead  phosphate
reaction product  (indicating  acid phosphatase  activity)  is demonstrable  within  these  mem-
brane-limited cytoplasmic  bodies, identifying them as morphological lysosomes.  The utiliza-
tion  of a  lysosomal  mechanism  in  sterol-synthesizing  cells,  which are  accumulating  choles-
tercl intermediates,  is discussed.
INTRODUCTION
During  the  past  ten  years  several  chemical  com-
pounds  have  appeared which  possess  the ability to
inhibit  cholesterol'  biosynthesis  both  in  vitro  and
1 Names  of  sterols  used  in  this  paper:  cholesterol
(A-cholesten-3  -ol),  desmosterol  (A5 24-cholestadien-
3 8-ol), and 7-dehydrocholesterol  (A5 
7-cholestadien-3
-ol).
in  vivo.  Three  structurally  different  drugs,
2 with
an  established  enzymatic  site  for  their  inhibitory
2 Names  of  drugs  used  in  this  paper:  triparanol
(MER-29,  I-[p(-diethylaminoethoxy)  phenyl]-l-
(p-tolyl)-2-(p-chlorophenyl)  ethanol);  20,25-diaza-
cholesterol  (SC-12937,  20,25-diazacholest-5-en-3
-oli  dihydrochloride);  AY-9944  (trans-1,4-bis  (2-
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FIGURE  1  An  abbreviated  diagram  of  cholesterol  biosynthesis.  MER-29  (triparanol)  and  SC-12937
(20,25-diazacholesterol)  are A24-reductase  inhibitors,  which  result in desmosterol accumulation.  AY-9944
is a A-reductase  inhibitor,  which  results in  7-dehydrocholesterol  accumulation.
effects,  have  been utilized  in the present investiga-
tion for a comparative study of the cellular mecha-
nisms  for  handling  accumulated  cholesterol  pre-
cursors.  Triparanol  (MER-29)  is  a  A24-reductase
inhibitor,  which  results  in  the  accumulation  of
desmosterol  (Fig.  1).  The  identity  of desmosterol
as  the principal  precursor  accumulating  with  ad-
ministration  of  triparanol  has  been  verified  by
ourselves  (37)  and  by  others  (4,  19).  20,25-
diazacholesterol  (SC-12937)  is  another  A24
reductase  inhibitor  having  a  chemical  structure
distinct  from  triparanol.  Desmosterol  (Fig.  1)  is
also  the  principal  precursor  which  accumulates
with  administration  of 20,25-diazacholesterol  (2,
33).  AY-9944  is  a  A 
7-reductase  inhibitor,  which
results in the accumulation  of 7-dehydrocholesterol
(Fig.  1).  The  identity  of  7-dehydrocholesterol  as
the  principal  precursor  accumulating  during  AY-
9944  administration  has  been  documented  pre-
viously  (14).
Previous  morphological  investigations  have
dealt with the cellular effects of triparanol upon the
adrenal  gland,  testis,  ovary,  liver,  and  pancreas.
Light microscopic  studies of triparanol-treated  rat,
monkey,  and  dog  adrenal  cortex  (26,  15,  43)
reveal  a  partial lipid  depletion  in  frozen  sections.
Yates  (44)  reports  that  the  dense  cytoplasmic
bodies  present in  the hamster  zona  fasciculata  are
histochemically  positive  for  phospholipid.  Ultra-
structural studies  of triparanol administration  in a
variety  of  cell  types  demonstrate  a  similarity  of
effects.  In  the  rat liver  and  pancreas,  Hruban  et
al.  (24,  25)  and  Swift  and  Hruban  (40)  describe
the  presence  of cytoplasmic,  membranous  whorls,
which  they  refer  to  as  "myeloid  bodies."  These
"myeloid  bodies"  fail  to react when  incubated in
the Gomori medium for acid phosphatase and have
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chlorobenzylaminomethyl)  cyclohexane  dihydro-
chloride).not  been  considered  "typical"  lysosomes.  Acid
phosphatase  is  demonstrable  when  "myeloid
bodies"  occur  inside  autophagic  vacuoles.  The
reaction  product  is  limited,  however,  to  that  por-
tion  of the  autophagic  vacuole  containing  non-
myeloid  cytoplasmic  material.  Hruban et al. con-
clude  that the predominant  effect  of triparanol  is
"highly specific"  and involves the accumulation  of
newly  formed,  abnormal,  membranous  material
in  the  cytoplasm.  Volk  and  Scarpelli  (43)  report,
in the triparanol-treated  rat adrenal gland, cellular
alterations  in  the  three  zones  of the cortex.  The
cortical  cells  contain  hypertrophied,  tubular,
smooth  endoplasmic  reticulum  and  dense  cyto-
plasmic  bodies  in  the zona  glomerulosa  and retic-
ularis.  These authors  interpret  the  primary  effect
of triparanol to be one of stimulation  of the smooth
endoplasmic  reticulum.  Yates  and  his  coworkers
(44,  45,  3,  8)  have  studied  the  response  of  the
Syrian  hamster  adrenal  cortex,  corpus  luteum,
testis,  and small  intestine to triparanol administra-
tion.  They  substantiate  the  earlier  reports  of the
appearance  of  opaque  cytoplasmic  bodies  and
hypertrophy of the smooth endoplasmic  reticulum.
The internal contents  of these  opaque cytoplasmic
bodies  appear  as  membranous  whorls,  as  a
crystalline  lattice  pattern,  or  as  a  "reticular"
network  of membranes.  Hruban  et  al.  (25)  and
Chen and Yates  (8)  believe that  the membranous
whorls  myeloidid  bodies,"  myelin  figures)  appear
first  and  transform,  during  continued  triparanol
administration,  into opaque  bodies with a "reticu-
lar"  or crystalline lattice  pattern.  Yates et al.  (45)
and  Arai  et  al.  (3)  have  obtained  an  adrenal
gland  cell  fraction  containing  the  opaque  cyto-
plasmic  bodies.  They  report  this  fraction  to  be
rich  in  desmosterol,  triparanol,  lipoprotein,  and
phospholipid.  Yates  et  al.  suggest  that  triparanol
induces  a cytoplasmic "lipodystrophy,"  character-
ized  by  a  disorganization  of  membranous  cell
structures.
The  present  investigation  was  undertaken  to
clarify  several  problems  relating  to  the  effects  of
triparanol:  (a)  the specificity  of triparanol in stim-
ulating  opaque  cytoplasmic  inclusions;  (b)  the
nature  of the drug response,  i.e.,  is  it the result of
inhibition  of  cholesterol  biosynthesis,  or  does  it
represent  a  response  unrelated  to this  effect;  and
(c)  the  identity  of the  drug-induced  inclusions  as
cellular organelles. The utilization of a sterol analy-
sis of the treated organs permits a chemical demon-
stration of drug effect and provides an indication of
treatment severity.  Comparative studies with three
different  inhibitors  allow conclusions  to  be formu
lated  regarding  triparanol  specificity  and  the  re-
lationship  of established  drug actions  to  the  stim-
ulation  of  cytoplasmic  inclusions.  This  study
reports  a  similar effect  of triparanol,  20,25-diaza-
cholesterol,  and  AY-9944  in  the  production  of
increased  numbers  of  pleomorphic,  membrane-
limited, cytoplasmic,  dense bodies.  Ultrastructural
acid  phosphatase  activity  is  demonstrable  within
these  membrane-limited  inclusions,  and  hence
they qualify  as  morphological  lysosomes.  Prelimi-
nary evidence  is  presented  for a  possible  origin of
these  morphological  lysosomes  from  the  smooth
endoplasmic  reticulum.  The  utilization  of  lyso-
somal  mechanisms  by steroid-synthesizing  cells  for
the  sequestration  of cholesterol  precursors  is  dis-
cussed.
MATERIALS  AND  METHODS
Adult  male  C3H mice  received  one  of the  drugs  in
four  evenly  spaced  intraperitoneal  injections  over
an 8-day  period.  Control  mice  consisted  of a  group
which  received  no  injections,  and  another  group
which  received  four  intraperitoneal  injections  of
olive  oil.  On  the  10th  day  following  initiation  of
therapy,  the mice  from each  drug and  control group
were  anesthetized  with  Nembutal  and  the  livers,
adrenal glands,  and testes  were excised.
The drugs and the doses utilized in this study were:
(a)  triparanol  (MER-29)3-300  mg/kg  as  an  olive
oil  solution  containing  10  mg/0.1  ml;  (b)  20,25-
diazacholesterol  (SC-12937)4-30  mg/kg as an aqueous
solution  containing  1 mg/0.1  ml; and  (c) AY-9944
5-
30 mg/kg as an aqueous solution containing  1 mg/0.1
ml.
Samples  of  the  livers,  adrenal  glands,  and  testes
representing  each  of the  drug  groups  were  analyzed
quantitatively  for  sterol  content.  Colorimetric  assay
for  sterols  employed  the  method  of Abell  et  al.  (1)
suitably  modified  for  the  estimation  of  desmosterol
(4)  and  7-dehydrocholesterol  (30).  In  addition,
infrared  and  ultraviolet  spectroscopy  were  used  to
verify the identity of these sterols in a manner similar
to that previously  described  (38).
3 We  wish  to  thank  A.  Wassermann,  S.p.A.  of
Societa  Italiana  per  Specialita  Farmaco-Tera-
peutiche,  Milan,  for the  gift of MER-29 used  in our
studies.
4 We wish  to thank Dr. R.  E. Ranney  of G.D.  Searle
and  Co.,  Skokie,  Ill.,  for  the gift of  SC-12937  used
in our studies.
5 We wish to thank Dr. D. Dvornik of Ayerst Labora-
tories,  Montreal, for  the  gift of AY-9944  used  in our
studies.
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Sterol Content of Mouse Liver,  Adrenal, and Testis
Desmosterol  7-Dehydrocholesterol  Other  sterols§
%  mg  %
0  0  0
64  0  0
35  0  0
0  0.068  29
5  0  0
26  0  0
26  0  0
0  0.427  25
0  0
40  0
21  0
0  0.033
mg  %
0  0
0  0
0.026  11
0  0
0
0.078
0.062
0
0
9
12
0
0  0  0
0  0  0
0  0  0
14  0  0
* Expressed  as mg  of sterol per  100  mg tissue,  wet weight.
:  Expressed  as % of total  sterol.
§ Based  upon rapid  (  -min)  color development  in  the  Liebermann-Burchard  reaction.
Adrenal glands  and testes, obtained simultaneously
with  the samples for chemical analysis, were prepared
for  routine  electron  microscopy.  Each  organ  was
fixed at room temperature by immersion in a solution
of  2%  formaldehyde-2.5%  glutaraldehyde  (17),
which  was  buffered  to  pH  7.2  with  0.2  M sodium
cacodylate  (22)  containing  0.05%  CaC12.  After  1 hr,
the  organs  were  diced  and  returned  to  the  fixative
for  another  hour.  Following  an  overnight  wash  in
0.1  M sodium cacodylate  (pH 7.2)  containing 0.05%
CaC12,  the specimens  were postfixed  for  2 hr at room
temperature  in  1  % osmium  tetroxide  buffered  to
pH  7.2  with  0.2  M sodium cacodylate.  Dehydration
was accomplished  in a graded series  of ethanols.  The
tissues were  embedded  in Epon 812  (29)  and polym-
erized  stepwise  at  37
°,  45
°,  and  60°C,  over  the
next  4  days.  Adrenals  from  mice  treated  with  each
drug  were  fixed also  for  2 hr in ice-cold  1  % osmium
tetroxide  without  prior  aldehyde  exposure.  These
adrenal  glands  were  then  processed  as  outlined
above.
Adrenal  glands  removed  from  the  triparanol-
treated group of mice were studied further by incuba-
tion  in a  modified  Gomori  medium  (see  reference  6
for details)  for the fine-structural  localization  of acid
phosphatase.  These  specimens were  fixed  for 2 hr  in
ice-cold  2%  formaldehyde-2.5%  glutaraldehyde,
which  lacked  the  CaC12  additive.  Following  a  5-hr
wash  in  several  changes  of 0.1  M cacodylate  buffer,
the tissue  blocks were sectioned  at 50  s on a Sorvall
TC-2  Tissue  Sectioner,  and  the  sections  were  incu-
bated  for  20  min  at  37°C  in  a  medium  containing
sodium  betaglycerophosphate,  lead  nitrate,  and
Tris-maleate  buffer  (pH  5)  (6).  The  omission  of
sodium  betaglycerophosphate  and  the  addition  of
0.01  M sodium  fluoride  to  the  routinely  prepared
medium  served  as  separate  controls  for  the  histo-
chemical  reaction.  All  sections  were  washed  in
succession  with  distilled  water,  2%  acetic  acid,  and
distilled water. Subsequent handling  of the tissue was
identical  to  the  procedures  outlined  above,  except
for  shorter  time  periods  in  osmium  tetroxide  and
the ethanol series.
Thick  sections  stained  with  azure  II-methylene
blue  (35)  were  examined  by  phase contrast  micros-
copy,  and  the  adrenal  cortex  and  testicular  inter-
stitium  were  identified.  Thin  sections,  cut  with  a
diamond  knife  on  a  Huxley  ultramicrotome,  were
stained  in alcoholic  uranyl  acetate  (21)  followed  by
lead  citrate  (34)  and  photographed  in  an  Hitachi
HU-IIA  or  HU-11IC  electron  microscope.
RESULTS
Chemical
Table  I  summarizes  our chemical  findings.  We
are  able  to  demonstrate,  in  the  organs  under
study, an accumulation  of the expected  cholesterol
precursors  associated  with  drug  administration.
In mature animals,  cholesterol  normally  accounts
for virtually all of the  sterol present  (see  untreated
control organs, Table I). While desmosterol  and 7-
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Organ Drug
Liver
Cholesterol
None
MER-29
SC-12937
AY-9944
%t
100
36
54
71
mg
0
0.102
0.085
0
Adrenal
Testis
mg*
0.156
0.057
0.131
0.165
0.830
0.566
0.320
1.28
0.273
0.159
0.204
0.207
None
MER-29
SC-12937
AY-9944
None
MER-29
SC-12937
AY-9944
95  0.040
65  0.227
62  0.134
75  0
100  0
60  0.106
79  0.054
86  0FIGURE  2  Portions  of three cells  in the normal  zona fasciculata.  Control adrenal  from a mouse  treated
with  olive  oil.  These  cells  possess  several  features  in common  with the  zona  glomerulosa:  (a)  a large,
ovoid  nucleus  (N) containing  a prominent  nucleolus  (No);  (b)  cytoplasmic lipid droplets  (L);  (e) a Golgi
zone  (G);  (d)  free  ribosomes (R); (e) an occasional  membrane-limited  dense body  (D); and (f) a smooth-
surfaced  endoplasmic  reticulum  (arrows).  Round  or  oval  mitochondrion  with  vesicular  or  flattened
saccular cristae, M.  *See Fig. 3 legend.  X  18,000.
48  THE  JOURNAL  OF  CELL  BIOLOGY  VOLUME  40,  1969FIGURE  3 a  An enlargement of the lipid droplet  (L*)  from Fig. 2. Preservation of the contents  is average
for the  conditions  of this  report.  Although  the plane  of  section  passes  close  to the droplet  center, there
is  no evidence  of  a trilaminar  unit-membrane  at any  point  (arrows)  along  the electron-opaque  limiting
interface.  X  88,000.
FIGURE  3  b  An  enlargement  of  the  dense  body  (D*)  from  Fig.  2.  A  trilaminar unit  membrane  is de-
inonstrable  limiting  the  entire  circumference  (arrows)  of  this  body.  It  is  unlikely  that fixation  would
permit  adequate preservation  of  this  limiting membrane  and  yet fail to preserve  the limiting  interface
of a  lipid droplet  (L*,  Fig.  ) only 300 ts distant.  X 88,000.
dehydrocholesterol  are  present  in  normal  mature
animals, these sterols occur  in only trace quantities.
The  percentage  accumulation  of  desmosterol  is
greater  in  MER-29-treated  mice  (liver  64c,
testis  40%,  and  adrenal  26%)  than  in  mice  re-
ceiving  SC-12937  (liver  35%,  testis  21%,  and
adrenal  26%).  Small  quantities  of  other  sterol
precursors,  presumed  by  their color  development
to  be  A
7- and/or As-sterols,  also occur in the liver
and adrenal of mice  receiving SC-12937  and in the
adrenal  of  MER-29-treated  mice.  This  observa-
tion  is  similar  to  the findings  of Clayton,  Nelson,
and Frantz  (11)  in the skin  of rats receiving  MER-
29.  AY-9944  results  in  the  accumulation  of  7-
dehydrocholesterol  (liver  29%,  testis  14%,  and
adrenal 25%).
Table  I  demonstrates  further  that  the response
of  different  organs  to  the  same  drug  may  vary
more  than  twofold,  i.e.,  64%  of the  liver  sterols,
compared  to  only  26%  of  adrenal  sterols,  exists
as desmosterol  following  MER-29  administration.
It  should  be  noted  that  substantial  amounts  of
cholesterol  occur  in the  liver,  adrenal  gland,  and
testis  following  treatment  with  all  three  drugs.
Such  data  suggest  that  complete  inhibition  of
cholesterol  biosynthesis  is  not  a  necessary  con-
comitant  to drug administration.
Normal Fine Structure
ZONA  FASCICULATA  AND  ZONA  GLOMER-
ULOSA:  The  reports  of  Zelander  (47,  48)  pro-
vide an extensive description  of the electron micro-
scopic appearance  of normal mouse adrenal gland.
His  work  should  be  consulted  for  the  many  de-
tails of the adrenal cortex peripheral  to this study.
S.  E.  DIETERT  AND  T.  J.  SCALLEN  Inhibitors of Cholesterol Biosynthesis 49FIGURE  4  A  portion  of  cytoplasm  from  a  testicular  Leydig  cell.  Control testis  from  a  mouse  treated
with olive oil. Illustrated are two cellular features  occurring  in this cell:  (a) an abundant  smooth-surfaced
endoplasmic  reticulum  (SER),  and  (b)  an  occasional  unit-membrane-limited  (arrows)  dense  body  (D).
These  dense  bodies  (D) may  contain  amorphous  masses  of  greater  density  (m)  and  electron-opaque
concentric  lamellae  (1).  X 88,000.
There are no significant  differences in morphology
between  the adrenal  cortices  of untreated  control
mice  and  the  adrenal  cortices  of control  mice  re-
ceiving  intraperitoneal  olive  oil.  We  conclude
that  the  olive  oil  vehicle  for  triparanol  in  the
quantities  used  in  this  investigation  is  innocuous
to  mice.  The  adrenal  cortical  fine  structure
of  C3H  mice  from  both  control  groups  sub-
stantiates  most  of  Zelander's  findings.  Cells  oc-
curring  in  the zona  fasciculata  (Fig.  2)  and  zona
glomerulosa  share  several  characteristics  in
common:  (a)  a  large,  ovoid  nucleus;  (b) cytoplas-
mic  lipid  droplets;  (c) a  prominent  Golgi  zone;
(d)  occasional  pleomorphic,  unit-membrane-
limited,  cytoplasmic,  dense  bodies  (Zelander's
"globules");  and  (e)  a  smooth-surfaced  endo-
plasmic  reticulum  consisting  of  intertwining
tubules,  channels,  vesicles,  and  small  vacuoles.
Adrenal cortical lipid  droplets  possess  an electron-
opaque interface  delimiting their contents from the
surrounding  cytoplasm.  We  have  been  unable  to
resolve,  in  the  many  planes  of section  in  which
these  lipid  droplets  are seen,  a single example  of a
trilaminar,  unit-membrane  structure  at  this inter-
face  (Fig.  3  a).  This  observation  is  in  agreement
with  the  descriptions  of  Fawcett  (18)  and  Long
and  Jones  (27,  28)  regarding  lipid  droplet  fine
structure  in  the  liver  and  adrenal.  A  trilaminar
unit-membrane  is  always  demonstrable,  in  a
favorable  plane  of  section,  delimiting  the  cyto-
plasmic  dense  bodies  (Fig.  3  b).  The  presence  of
this trilaminar,  limiting,  unit-membrane  serves as
a reliable  characteristic  for  distinguishing  the  two
inclusions.  These  dense  bodies  may contain  con-
centric  lamellae  of greater  density  as  an  accom-
panying  component  to  the  finely  granular,  mod-
erately  dense  matrix.  Similar  dense  bodies  in  the
normal  rat  adrenal  cortex  possess  fine-structural
acid  phosphatase  and  qualify  as  morphological
lysosomes  (32,  41).
TESTICULAR  LE  Y  DIG  CELLS:  Christensen
and  Fawcett  (10)  have  published  recently  a  de-
tailed study of the ultrastructure of mouse testicular
Leydig  cells.  The following  description  is  confined
to  those  Leydig  cell  features  pertinent  to  the
present  study.  No  important  morphological  dif-
50  THE  JOURNAL  OF  CELL  BIOLOGY  VOLUME  40,  1969FIGURE  5  Portions of  six adrenal cortical cells from a mouse treated  with MER-29.  The cellular effects
of  this  drug  are  identical  with  the effects  following  SC-12937  and  AY-9944.  Administration  of  these
drugs  is  associated  with  a  marked  increase  in  the  number  of  pleomorphic,  membrane-limited,  cyto-
plasmic  dense bodies  (D).  Compare  the presence  of nine  dense  bodies  (D) in Fig.  5 with  the occurrence
of only two dense bodies  (D) in control adrenal  (Fig.  2). The predominant dense body shape  is a slightly
irregular,  round-to-ovoid  form.  The  figure  allows  a  comparison  of  the  elongate  mitochondria  in  the
zona glomerulosa  (Mg) with the round or ovoid mitochondria  in the zona  fasciculata  (Mf).  Nucleus,  N;
ribosomes,  R; smooth endoplasmic  reticulum,  arrow.  X  18,000.
51ferences occur between Leydig cells from untreated
control  mice  and  Leydig  cells  from  control  mice
treated  with  intraperitoneal  olive  oil.  The  Leydig
cell  fine  structure  of  both  control  groups  agrees
closely  with  earlier  reports  (10).  Fig.  4  depicts  a
portion of a typical  Leydig  cell  and illustrates cer-
tain morphological  features  which are  present  in
these cells:  (a)  an abundant smooth-surfaced  endo-
plasmic  reticulum  consisting  of  anastomosing
tubules  associated  with scattered  vesicles and small
vacuoles,  and  (b)  occasional  pleomorphic,  unit-
membrane-limited,  cytoplasmic,  dense  bodies.
These bodies appear identical  to their counterpart
in  the  adrenal  cortex  and  usually  possess  a finely
granular  matrix  of moderate  density.  Such inclu-
sions  also  may  contain  amorphous  masses  of
greater  density  and  electron-opaque  concentric
lamellae  (Fig.  4).
Cytological Effects of  Triparanol, 20,25-
Diazacholesterol, and A Y-9944
INTRODUCTION:  Triparanol,  20,25-diaza-
cholesterol,  and AY-9944 produce identical cellular
alterations  in  the  zona  glomerulosa,  zona  fas-
ciculata,  and testicular Leydig cells. Administration
of these  drugs  is associated  with  the  appearance
of increased  numbers of pleomorphic,  membrane-
limited,  cytoplasmic,  dense  bodies.  The  effects
of  these  drugs  are  readily  apparent  when  the
affected  cells  are  examined  in the  electron  micro-
scope.  Fig.  5  demonstrates  the  presence  of  nine
dense  bodies  in  a  typical  area  from  MER-29-
treated  adrenal  cortex.  This  represents  a  signifi-
cant  increase  over  the  two  dense  bodies  visible
in  a  typical  area  (at  the  same  magnification)  of
control  adrenal  (Fig.  2).  Similar  fine-structural
alterations  have  been  reported  in  a  variety  of
cell  types  by  several  workers  (24,  25,  40,  43-45,
3,  8,  46).  It  is  important  to  emphasize  that  the
morphological  alterations  associated  with  drug
administration  are  abnormal  in  relation  to  the
increased  quantity  of  cytoplasmic  dense  bodies.
Similar  membrane-limited  dense  bodies  occur  in
the untreated  control cells,  but in  greatly reduced
numbers.
DENSE  BODY  FINE  STRUCTURE:  Drug-in-
duced  dense  bodies  occur  exclusively  in  the  cell
cytoplasm  (Fig.  5).  Similar  structures  have  not
been  encountered  within  the  nuclei  of  cells
exposed  to  the  inhibitors.  These  bodies  appear
to  be  distributed  randomly  in  the  cytoplasm.
Dense  body  diameters  measure  approximately
0.4-1.0  /u. Although  the  shape  of  these  bodies  is
variable,  a slightly  irregular,  round-to-ovoid  form
predominates  (Fig.  5).  At  higher  magnification,
these  dense  bodies,  which  are  identical  to  those
depicted  in  Fig.  5,  are  delimited  clearly  by  a
trilaminar  unit-membrane  (Figs.  6,  7,  and  9).  In
this  respect,  they  are  also  identical  to  the  dense
bodies  present  in  control  preparations,  as  shown
in Figs.  3  b  and 4. The contents  of these bodies are
FIUHRE  6  A portion  of cytoplasm  in an adrenal  cortical  cell  from a mouse  treated with
SC-12937.  The  dense  body  (D)  is  filled  with  a  homogeneous,  highly  electron-opaque
material  and  is delimited  clearly  by  a trilaminar  unit-membrane  (arrows).  A  trilaminar
unit-membrane  is also visible  limiting the dense  bodies  (D) in  Figs. 7 and  9.  OsO4 fixed.
X  83,000.
FIGuRE  7  A  portion  of  cytoplasm  in  an  adrenal  cortical  cell  from  a  mouse  treated
with SC-12937.  The  dense  body  (D) contains  a finely  granular  matrix  of  moderate  elec-
tron opacity (*)  and concentric,  regularly stacked  lamellae  (arrows)  composed  of electron-
opaque  material.  Some  vesiculation  of  the  smooth  reticulum  (SER),  which  occurs  in-
consistently  with OsO4,  is apparent.  OsO4 fixed.  X 83,000.
FIGURE  8  A portion  of cytoplasm  in a Leydig  cell from a mouse  treated with  MER-29.
The  dense  body  (D)  contains  a concentric,  irregular  lamination  of  membranes  (arrows)
forming  a  myelin  figure  (membranous  whorl).  Vesiculation  of  the  smooth  reticulum
(SER)  is essentially  absent.  OsO4  fixed.  X 44,000.
FIGURE  9  A  portion  of  cytoplasm  in  an  adrenal  cortical  cell  from  a  mouse  treated
with  SC-12937.  The  dense  body  (D)  has  a finely  stranded,  mesh-work  arrangement  of
the  electron-opaque  material,  which  imparts  a  "reticular"  pattern  (arrow)  to  the con-
tents (Chen and Yates' Type III body).  Os04 fixed.  X  83,000.
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different drug. The dense bodies  (D) possess a crystalline lattice arrangement  of electron-opaque material,
resulting in a rectangular  or hexagonal repeating  array (Chen and Yates' Type IV body).  Fig. 10, treated
with MER-29; Fig.  11, treated with SC-12937; and Fig.  12,  treated with AY-9944.  Ribosomes, R; smooth
endoplasmic  reticulum,  SER. OsO4  fixed.  X  83,000.
FIGURE  13  A portion of  cytoplasm  in an adrenal  cortical  cell from a  mouse treated  with  AY-9944.  A
smooth-surfaced,  membrane-limited  vesicle  (arrow)  occurs  in  the  cytoplasm  and  appears  similar  to
adjacent smooth reticulum  (SER). This  vesicle (arrow)  is noteworthy  in the presence  of electron-opaque
material (m) within the cisternal  space. Compare the similar electron opacity of this material  (m) with the
opaque material  present in many dense bodies  (Fig. 6). Dense body, D. 0s0 4 fixed.  X 83,000.FIGURE  14  A  portion of  cytoplasm  in an  adrenal cortical  cell from  a mouse  treated  with SC-1297. A
smooth-surfaced,  membrane-limited  vesicle  (arrow)  occurs  in  the cytoplasm,  which  appears  similar  to
adjacent  smooth  reticulum  (SER). This  vesicle  (arrow)  contains  electron-opaque  material  (m),  which
displays  a  lamellar  organization,  within the  cisternal  space.  Compare  the similar  electron  opacity  and
lamellar  organization  of  this material  (m)  with the concentric  lamellae visible  inside  some dense  bodies
(Fig. 7).  Dense body, D. Os04 fixed.  X  88,000.
pleomorphic  and  exist  (often  in combination)  in
several recognizable  forms;  (a)  as a finely granular
matrix  of moderate  electron opacity  (Fig.  7);  (b)
as  a  homogeneous,  amorphous,  highly  electron-
opaque  material,  which  may  fill  the  body  and
obscure  further  detail  (Fig. 6);  (c) as concentric,
regularly  stacked  lamellae  composed  of  the  elec-
tron-opaque material  (Fig.  7);  (d)  as a concentric,
irregular  lamination  of  membranes  forming  a
myelin  figure  or  membranous  whorl  (Fig.  8),
which appears identical  to Chen  and Yates' Type
I  body  (8);  (e) as  a finely stranded,  meshwork  ar-
rangement  of the opaque  material,  which imparts
a "reticular"  pattern  to the contents  (Fig.  9), and
appears  identical  to  Chen  and  Yates'  Type  III
"reticular"  body  (8);  and  (f)  as  a  crystalline
lattice  arrangement  of opaque  material  resulting
in  a  rectangular  or  hexagonal  repeating  array
(Figs.  10-12),  which  appears  identical  to  Chen
and  Yates'  Type  IV  body  (8).  Contrary  to  the
data  of Yates  et  al.,  reporting  the  presence  of  a
crystalline lattice structure in hamster dense bodies
only  after triparanol administration  (46),  we  have
been able to  demonstrate  a crystalline  lattice pat-
tern  in  dense bodies  of the murine  adrenal cortex
following  treatment  with  triparanol  (Fig.  10),
20,25-diazacholesterol  (Fig.  11),  and  AY-9944
(Fig.  12).  All  of these  parameters  of fine structure
are shared  by the  dense bodies,  which accumulate
in  both  adrenal cortex and Leydig  cells,  following
administration  of each of the drugs under study.
EFFECTS  OF  FIXATION:  Two  fundamental
types  of  fixation  have  been  employed  in  this
study:  (a)  a mixture  of formaldehyde-glutaralde-
hyde  followed  by  osmium tetroxide  (17),  and  (b)
initial  osmium  tetroxide,  omitting  any  aldehyde
exposure.  The  former  permits  the  most  effective
preservation  of  the  numerous  cell  constituents,
especially the smooth-surfaced endoplasmic  reticu-
lum, which  often dilates and  forms vesicles  under
less than optimal conditions  (10).  Osmium  tetrox-
ide  appears  to  be  an  adequate  fixative,  although
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as  an  inconsistent  finding  (compare  Fig.  7  with
Fig.  8).  Dense  body  fine  structure  is  identical,
however,  under  both  fixation  procedures.  An
exception  to  this generalization  is  the  presence  of
a  crystalline  lattice  structure  in  the  contents  of
certain dense bodies following drug administration
(Figs.  10-12).  The  ease with  which such a lattice
pattern  can  be  demonstrated  is  increased  greatly
by  fixation  in  osmium  tetroxide.  We  are  not
prepared  to  state,  however,  that  lattice  patterns
occur  exclusively  in  osmium  tetroxide-fixed
material.
PRESUMPTIVE  SMOOTH-SURFACED  ENDO-
PLASMIC  RETICULUM.  Earlier  workers  have
reported  that  a  hypertrophy  of the smooth  endo-
plasmic  reticulum  is  associated  with  triparanol
administration  (43, 44).  At the relatively  low level
of precursor  accumulation  achieved  in the present
study, we are  unable to document convincingly  an
increase  in  the  quantity  of smooth  endoplasmic
reticulum  in  murine  adrenal  cortex  and  Leydig
cells.  Following  treatment  with  each  drug,  how-
ever,  smooth-surfaced,  membrane-limited  vesicles
and  tubules  measuring  approximately  50-90  ms
across  the  smallest  diameter  are  encountered  in
the cytoplasm.  These vesicles and tubules are simi-
lar  to  adjacent  elements  of  the  smooth-surfaced
endoplasmic  reticulum  and are  noteworthy  in the
presence  of electron-opaque  material  within  the
cisternal  space  (Figs.  13  and  14).  The  electron
opacity  of this  cisternal  material  is similar  to the
density  of the  opaque  material  present  in  many
dense bodies (compare  Figs.  13 and 14 with Fig. 6).
Occasionally,  the opaque cisternal contents display
a lamellar organization suggestive of the concentric
lamellae  visible  within  dense  bodies  (compare
Fig.  14 with Fig. 7).  Morphologically, the cisternal
contents  of these  vesicles are similar,  if not identi-
cal, to the contents of the dense cytoplasmic bodies.
Acid Phosphatase Localization
Adrenal  glands  from  triparanol-treated  mice
have  been  examined  for  the  fine-structural
localization  of acid  phosphatase.  The  demonstra-
tion  of  this  hydrolytic  enzyme  activity  within
membrane-limited,  cytoplasmic  bodies  fulfills
the  criteria  of Essner  and  Novikoff  (16)  for  the
identification  of  such  bodies  as  morphological
lysosomes.  Following  the  incubation  of  adrenal
gland  sections in  a betaglycerophosphate  medium
containing  lead  nitrate,  electron-opaque,  lead
phosphate  reaction  product  (indicating  acid
phosphatase  activity)  is  demonstrable  within  the
drug-induced  dense bodies  (Figs.  15 and  16).  The
accumulation  of  lead reaction  product  is  limited
precisely  within  the  membrane-defined  extent  of
these  bodies.  Examples  occur  of enzyme-positive
bodies  which  possess  contents  having  most of  the
fine-structural  forms  outlined  above.  Fig.  15
represents  a  "reticular"  form  (Yates'  type  III)
and  Fig.  16  is a myelin  figure  (Yates'  type I).  An
estimate  of  the  relative  number  of  dense  bodies
which  are  enzyme-positive  is  about  20%.  Extra-
neous  lead  precipitate  occurs  occasionally  as  a
nonspecific  speckling  over  the  nucleus  or  cyto-
plasm. Vigorous washing  (see Methods)  is effective
in reducing  this artifact.  Control sections are  incu-
bated in  a  medium  lacking  betaglycerophosphate
and in an intact medium  containing 0.01  M sodium
fluoride  (a potent phosphatase  inhibitor).  Sections
handled in this manner are consistently unreactive.
DISCUSSION
A comparison  of the  biochemical  and  ultrastruc-
tural effects  of inhibitors  of cholesterol  biosynthesis
provides one method for the study of cellular mech-
anisms  of  sterol  metabolism.  The  intent  of  the
present study is an investigation  of the cytological
responses  of steroid-synthesizing  cells  to  the accu-
mulation  of  cholesterol  precursors,  normally
present  in  only  trace  amounts.  An  attempt  has
been made, by the utilization of low inhibitor doses,
to  achieve  a submaximal  blockade  of  cholesterol
biosynthesis.  The  demonstration  of  substantial
quantities  of  cholesterol  in  the  drug-treated
organs  (see  Chemical  Results)  suggests  that  a
submaximal  effect  has  occurred.  The  authors
believe  that  greater  insight  into  mechanisms  of
sterol metabolism can be obtained  by the  study of
cells  not rendered  severely  toxic through maximal
drug effects.
Triparanol,  20, 25-diazacholesterol,  and  AY-
9944  represent  chemically  distinct  inhibitors.
They share,  however, two distinguishing character-
istics:  (a)  they  interrupt  terminal  stages  of  cho-
lesterol  biosynthesis  by  means of reductase inhibi-
tion,  and  (b)  they  produce  identical  cytological
alterations  in  adrenal  gland  and  testis.  We  con-
clude, therefore, contrary to the reports  of Hruban
et al.  (24,  25,  40),  that  the morphological  altera-
tions  following  triparanol  administration  are
neither  "specific"  nor unique.  The  accumulation
of pleomorphic,  membrane-limited,  dense  bodies
56  THE  JOURNAL  OF  CELL  BIOLOGY  · VOLUME  40,  1969FIGURES  15  and  16  Portions  of  cytoplasm  in  two  adrenal  cortical  cells  from  a  mouse  treated  with
MER-29.  Incubated  in  a Gomori  medium  (pH  5)  for  localization  of  acid  phosphatase  activity.  Lead
phosphate  reaction product  (*)  is demonstrable  with in  the membrane-limited  confines  (arrows)  of these
cytoplasmic  dense bodies (D).  These features  fulfill  the criteria  of Essner and Novikoff  (16)  for an identi-
fication  of  MER-29-induced  dense  bodies  as  morphologic  lysosomes.  Fig.  15  represents  an  enzyme-
positive "reticular"  body. Fig.  16 is an enzyme-positive  myelin figure. Mitochondrion,  M.  X  55,000.
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three  drugs.  It  seems  probable  that  this common
cytological  response  is  related  directly  to  the
shared  inhibitory  effects  which  these  drugs  have
upon cholesterol  biosynthesis.
Fine-structural  localization  of acid  phosphatase
activity  has  been  demonstrated  in  triparanol-
induced  dense  bodies  within  the  adrenal  cortex.
Approximately  20%  of the  dense bodies examined
demonstrate  the  presence  of  lead  phosphate
reaction product.  This observation  does not imply
that the unreactive  dense  bodies  differ in  identity
from enzyme-positive  bodies. Several explanations,
probably acting in  combination,  exist  for the lack
of  reactivity  of  some  lysosomal  dense  bodies.
Gahan  (20),  Novikoff (31),  and Barka and Ander-
son  (7)  should  be  consulted for  a detailed  discus-
sion  of  the  problems  related  to  the  histochemical
identification  of lysosomes.  No statement is possible
regarding  the  acid  phosphatase  positivity  of
crystalline  lattice  bodies  (Yates'  type  IV)  since
the  use  of  initial  osmium  tetroxide  fixation  to
facilitate  their  demonstration  destroys  enzyme  ac-
tivity  (36).  We  believe  that  each  of these  mem-
brane-limited  dense  bodies  represents  a  morpho-
logical  lysosome involved  in a spectrum of internal
reorganizations.  The  various  fine-structural  forms,
which  the  contents  assume,  do  not  indicate  a
difference  in identity between  bodies, but probably
represent  physiochemical  alterations  of the  body
contents  (5).  We  speculate  that  the  formation  of
lysosomes  in  response  to  increased  whole  organ
levels  of cholesterol  precursors  is  the  result  of  a
selective  compartmentalization  of  accumulating
precursors  within  these  membrane-limited  or-
ganelles.  Since  the  chemical  analyses  have  not
been  performed  on  isolated  granule  fractions,  we
have  no evidence  at this time  regarding  the non-
enzymatic  content  of drug-induced  dense  bodies.
However Yates et al.  (45) and Arai et al.  (3)  report
that  a  cell  fraction  from  hamster  adrenal  gland,
which  contains  triparanol-induced  dense  bodies,
is  rich  in desmosterol,  triparanol,  lipoprotein,  and
phospholipid.  Such  findings  are  compatible  with
our  belief that  precursor  sequestration  is  involved
in  the formation  of these lysosomes.  An indication
of  the  effectiveness  of  cellular  mechanisms  in
handling  these  accumulating  precursors  is  the
ability of littermate  mice to reach sexual maturity,
breed,  and  reproduce  viable  offspring,  while
receiving 0.5  mg/day of triparanol  from 5  days of
age.  The  livers  of  these  viable  offspring  contain
approximately  50%  of their  sterols in  the form  of
desmosterol.
A  group  of storage  diseases  referred  to  as  the
lipidoses  provide  a  possible  clinical  correlate  to
the cholesterol inhibitor-induced  lysosome response
reported  here.  Tay-Sachs'  disease,  an  example  of
ganglioside  storage,  is  considered  by  many  in-
vestigators  to  result  from  a  deficiency  in  one  or
several  specific  hydrolytic  enzymes  (39).  All
workers  agree  that  metabolic  intermediates  ac-
cumulate  in  association  with  the  appearance  of
membranous  cytoplasmic  bodies  (myelin  figures)
in  the  central  nervous  system.  Volk  (42)  has
demonstrated  the  presence  of  acid  phosphatase
activity  within  these  membranous  inclusions.  It
is  interesting  to  speculate  that  the  abnormal
storage  of gangliosides  in  Tay-Sachs'  disease  may
result from  enzyme  deficiencies  within  lysosomes.
The  drug-induced  accumulations  of  cholesterol
precursors,  which  have  been  reported  in  this
study,  may  represent  an  alternative  leading  to
lysosome  accumulation,  i.e.,  entrance  of  sterol
substrates  into  a  mammalian  lysosome  system,
which  lacks  the  degradative  enzymes  necessary
for  the  catabolism  of the  cyclopentanoperhydro-
phenanthrene  ring  (see  reference  23  for  a  discus-
sion  of sterol  metabolic  pathways  and  end  prod-
ucts).  The  stimulation  of  this  lysosome  response
suggests  that  the  accumulating  precursors  are
unable  to  substitute  for  cholesterol  in  normal
cellular metabolism.
If the  cholesterol  biosynthesis  inhibitors,  which
have  been  employed  in  this  investigation,  result
in  a  pronounced  lysosome  response  within  the
afflicted  cells,  the  question  arises  regarding  the
origin  of  these  dense  bodies.  Chesterton  (9),  and
numerous  other  workers  within  the  last  decade,
agree that  the cellular location  of most  (if not  all)
of the enzymes  involved  in cholesterol biosynthesis
is  the  endoplasmic  reticulum  (i.e.,  microsome
fraction).  An  extensive  manipulation  of  drug
doses, administration schedules,  and time sequence
studies would be  required to undertake a definitive
morphological  investigation  of dense  body origin.
These  represent  some  of the variables  which have
been kept constant in  the present study in order to
simplify  the  comparison  of the  cellular  effects  of
different  inhibitors  of cholesterol  biosynthesis.  In
spite  of  these  limitations,  we  observe  following
inhibitor  administration  the  presence  of electron-
opaque  material  within  the cisternae  of vesicular
and tubular elements,  which appear similar  to the
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son  of  electron  opacity  and  lamellar  organiza-
tion,  such  cisternal  contents  are  morphologically
similar  to  the  opaque  contents  of  cytoplasmic
dense  bodies  (compare  Figs.  13  and  14  with
Figs.  6  and  7).  Although  preliminary,  and  by  no
means  unequivocal,  these  findings  suggest  that  a
possible  origin  for  the  dense  bodies  and  their
opaque contents  is an elaboration  from the smooth
reticulum.  The  endoplasmic  reticulum,  the Golgi
complex,  and the GERL  of Novikoff all have been
implicated  in  lysosome  production  in  a  wide
variety  of  cell  systems  (12).  The  authors  suggest
that  the  smooth-surfaced  endoplasmic  reticulum,
as  the  location  of  the  enzyme  systems  active  in
cholesterol  biosynthesis  (23,  9),  is  a  logical
organelle  in  which accumulating  desmosterol  and
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